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The exact prevalence of IEM in the adult population is currently unknown. As mentioned previously, 81 there are two main groups requiring the involvement of knowledgeable clinical providers in this 82 population. Genetic disorders with adult-onset forms (see Table 1 ), and conditions that present in 83 childhood or adolescence but either due to their slowly progressive course or effective treatment, 84 become chronic conditions with prolonged life expectancy [19] (see Table 2 ). Both groups will benefit 85 from a comprehensive and systematic approach to their care.
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There is currently no agreed upon answer to the question of who assumes responsibility for the conclusively. There is currently no general established guidelines as to who owns primary responsibility providers ready to take on this growing population and a good starting point to identify conditions to 
